Intravesical gemcitabine and docetaxel in patients with recurrent high-grade nonmuscle invasive bladder cancer—A prospective cohort study
In patients with recurrent HG NMIBC who are unfit or reluctant to undergo radical cystectomy and in whom BCG failed, intravesical gem/doce was effective and safe.
Authors
- Arnout R. Alberts (ORCID: https://orcid.org/0000-0003-4358-2840)
- Daniëlle C. van Diepen (ORCID: https://orcid.org/0000-0003-1692-0832)
- Steven L. Bosch (ORCID: https://orcid.org/0000-0002-7947-8853)
- Tahlita C.M. Zuiverloon
- J.Y. Zee
- Kim E.M. van Kessel
- Joost L. Boormans
- Olga M Pijpers (ORCID: https://orcid.org/0000-0002-5392-4245)
Institutions
- Amphia Ziekenhuis (NL)
- Erasmus MC Cancer Institute (NL)
Publication Details
- Journal
- Urologic Oncology Seminars and Original Investigations
- Published
- 2025-05-05
- DOI
- https://doi.org/10.1016/j.urolonc.2025.03.024
- Citations
- 3
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 6.02